Zydus Cadila gets FDA tentative approval for Sitagliptin base tablets
Zydus Cadila said that its subsidiary has been granted tentative approval from the US Food and Drug Administration (FDA) for its new drug application (NDA) for Sitagliptin base 25, 50, and 100 mg tablets. The Indian pharma company said that Sitagliptin base has the active moiety Sitagliptin in a different form than the one used […]